Myelin formation is the process by which oligodendrocytes (in the CNS) and Schwann cells (in the PNS) wrap neuronal axons with a multi-layered lipid-rich membrane. This process is essential for rapid saltatory conduction of action potentials and provides metabolic support to axons. Dysregulation of myelin formation and maintenance is implicated in various neurodegenerative diseases including [multiple sclerosis](/diseases/multiple-sclerosis), [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [amyotrophic lateral sclerosis](/diseases/als) [@nave2023].
Cellular Components
Oligodendrocytes (CNS)
[Oligodendrocytes](/cell-types/oligodendrocytes) are the myelin-forming cells in the central nervous system:
Progenitor cells (OPCs): NG2-positive cells that proliferate and differentiate into mature oligodendrocytes [@nishiyama2009]
This section highlights recent publications relevant to this mechanism.
[Neuromodulatory role and therapeutic potential of N 6 -methyladenosine RNA methylation in neurodegenerative diseases.](https://pubmed.ncbi.nlm.nih.gov/40618260/) (2026 Jun 1) - Neural regeneration research
[Neuronal TLR4 upregulation activates the cGAS-STING pathway to induce ferroptosis in EAE mice.](https://pubmed.ncbi.nlm.nih.gov/41702081/) (2026 Apr 1) - International immunopharmacology
[Human Myelin Spheres for in Vitro Oligodendrocyte Maturation, Myelination and Neurological Disease Modeling.](https://pubmed.ncbi.nlm.nih.gov/41593300/) (2026 Apr) - Stem cell reviews and reports
[Recent Updates on Lipid Landscapes in Neonatal and Adult Neurological Disorders: Advancing Mass Spectrometry and Lipidomics for Disease Insight: A Systematic Review.](https://pubmed.ncbi.nlm.nih.gov/41833039/) (2026 Mar 11) - CNS & neurological disorders drug targets
References
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Unknown (n.d.)
Pathway Diagram
The following diagram shows the key molecular relationships involving Myelin Formation discovered through SciDEX knowledge graph analysis: